S. M. Lippman

4.2k total citations · 1 hit paper
48 papers, 3.2k citations indexed

About

S. M. Lippman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, S. M. Lippman has authored 48 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 14 papers in Otorhinolaryngology. Recurrent topics in S. M. Lippman's work include Lung Cancer Treatments and Mutations (14 papers), Head and Neck Cancer Studies (14 papers) and Retinoids in leukemia and cellular processes (7 papers). S. M. Lippman is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Head and Neck Cancer Studies (14 papers) and Retinoids in leukemia and cellular processes (7 papers). S. M. Lippman collaborates with scholars based in United States, Switzerland and Mexico. S. M. Lippman's co-authors include Waun Ki Hong, R. Lotan, Loretta M. Itri, Stimson P. Schantz, Alan Kramer, Isaiah W. Dimery, Daniel D. Karp, Robert M. Byers, Helmuth Goepfert and Lester J. Peters and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

S. M. Lippman

46 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck

1990 1.1k citations Waun Ki Hong, S. M. Lippman et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by S. M. Lippman

Since Specialization

Citations

This map shows the geographic impact of S. M. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. M. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. M. Lippman more than expected).

Fields of papers citing papers by S. M. Lippman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. M. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. M. Lippman. The network helps show where S. M. Lippman may publish in the future.

Co-authorship network of co-authors of S. M. Lippman

This figure shows the co-authorship network connecting the top 25 collaborators of S. M. Lippman. A scholar is included among the top collaborators of S. M. Lippman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. M. Lippman. S. M. Lippman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival 2011 ·Annals of Oncology ·William N. William, (unknown), (unknown), Luisa M. Solis, Carmen Behrens, J. Jack Lee, S. M. Lippman, Sung‐Min Kim, Waun Ki Hong, Ignacio I. Wistuba, Ho‐Young Lee	57
2	Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma. 2010 ·Journal of Clinical Oncology ·(unknown), Ignacio I. Wistuba, Reza J. Mehran, Justyna Gil, (unknown), (unknown), (unknown), S. M. Lippman, W. K. Hong	8
3	The Role of Neck Dissection After Chemoradiotherapy for Oropharyngeal Cancer With Advanced Nodal Disease 2001 ·Archives of Otolaryngology - Head and Neck Surgery ·Gary L. Clayman, (unknown), William B. Morrison, Lawrence E. Ginsberg, S. M. Lippman	81
4	Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. 2000 ·PubMed ·Madeleine Duvic, (unknown), Claudia Schulz, (unknown), (unknown), C Hager, (unknown), P Hazarika, Bettie S. Jackson, Joan Breuer-McHam, Jim Young, Gary L. Clayman, S. M. Lippman, (unknown), Nancy Robinson, Anne Deucher, Richard L. Eckert, Sunil Nagpal	60
5	Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. 2000 ·PubMed ·Fadlo R. Khuri, Dong M. Shin, Bonnie S. Glisson, S. M. Lippman, Waun Ki Hong	66
6	Advances in the Development of Retinoids as Chemopreventive Agents 2000 ·Journal of Nutrition ·S. M. Lippman, R. Lotan	104
7	Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy 1998 ·JNCI Journal of the National Cancer Institute ·Li Mao, V. Papadimitrakopoulou, Dong M. Shin, You-Hong Fan, Xiaogen Zhou, J. S. Lee, W. K. Hong, A. K. El-Naggar, Hee‐Chul Shin, Gary L. Clayman, J. Jack Lee, WN Hittelman, S. M. Lippman	122
8	Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. 1997 ·Journal of Clinical Oncology ·Frank V. Fossella, S. M. Lippman, Dong M. Shin, Peter G. Tarassoff, (unknown), Román Pérez-Soler, (unknown), William K. Murphy, Bonnie S. Glisson, (unknown), (unknown)	104
9	Phase II study of cisplatin, 5-fluorouracil and interferon-α in recurrent carcinoma of the cervix 1995 ·Investigational New Drugs ·(unknown), S. M. Lippman, Andrzej P. Kudelka, Creighton L. Edwards, J. J. Kavanagh	5
10	Biology and reversal of aerodigestive tract carcinogenesis 1995 ·Cancer treatment and research ·S. M. Lippman, Gary L. Clayman, Martin H. Huber, Steven E. Benner, Waun Ki Hong	3
11	Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck 1994 ·Investigational New Drugs ·Martin H. Huber, Isaiah W. Dimery, Steven E. Benner, S. M. Lippman, Mihran Shirinian, Benjamin Esparaz, (unknown), (unknown), Waun Ki Hong	3
12	Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. 1993 ·PubMed ·W K Hong, S. M. Lippman, Gregory T. Wolf	51
13	13-cis-Retinoic Acid Plus Interferon- 2a in Locally Advanced Squamous Cell Carcinoma of the Cervix 1993 ·JNCI Journal of the National Cancer Institute ·S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza, (unknown), Patricia Paredes-Casillas, W. K. Hong, Giorgio Massimini, (unknown), I. H. Krakoff	76
14	Micronuclei: A potential intermediate marker for chemoprevention of aerodigestive tract cancer 1993 ·Journal of Cellular Biochemistry ·Steven E. Benner, Michael J. Wargovich, S. M. Lippman, Waun Ki Hong	7
15	Chemoprevention Strategies in Lung Carcinogenesis 1993 ·CHEST Journal ·S. M. Lippman, Steven E. Benner, Waun Ki Hong	18
16	13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin 1992 ·JNCI Journal of the National Cancer Institute ·S. M. Lippman, David Parkinson, Loretta M. Itri, Randal S. Weber, Stimson P. Schantz, David M. Ota, Mark A. Schusterman, I. H. Krakoff, Jordan U. Gutterman, W. K. Hong	305
17	13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix 1992 ·JNCI Journal of the National Cancer Institute ·S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza, (unknown), Patricia Paredes-Casillas, Waun Ki Hong, (unknown), I. H. Krakoff	259
18	Biomarkers: Intermediate endpoints for upper aerodigestive tract chemoprevention trials 1992 ·Steven E. Benner, S. M. Lippman, (unknown), WN Hittelman, Waun Ki Hong	1
19	Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck breakdown → 1990 ·New England Journal of Medicine ·Waun Ki Hong, S. M. Lippman, Loretta M. Itri, Daniel D. Karp, (unknown), Robert M. Byers, Stimson P. Schantz, Alan Kramer, R. Lotan, Lester J. Peters, Isaiah W. Dimery, Bethany L. Wagner, Helmuth Goepfert	1065
20	Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration 1988 ·Cancer ·S. M. Lippman, (unknown), Donald J. Slymen, Sheldon Weiner, Silvio A. Aristizabal, (unknown), (unknown), (unknown)	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact